Roche Holding AG (LON:0QQ6)
London
· Delayed Price · Currency is GBP · Price in CHF 261.80
+3.00 (1.16%)
At close: Aug 13, 2025
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
564.35K GBP
Profits / Employee
83.82K GBP
Market Cap
196.22B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Oxford Nanopore Technologies | 1,382 |
| HUTCHMED (China) | 1,811 |
Roche Holding AG News
- 10 days ago - Roche gets FDA clearance for respiratory test to detect viruses - Seeking Alpha
- 13 days ago - Roche's Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD) - GlobeNewsWire
- 13 days ago - Genentech's Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD) - Business Wire
- 16 days ago - Trump's pharmaceutical tariffs could affect some drugmakers more than others - CNBC
- 16 days ago - U.S. and European Union trade deal could cost the pharma industry up to $19 billion - Fast Company
- 17 days ago - EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say - Reuters
- 17 days ago - FDA Probes Death Of 8-Year-Old Who Received Sarepta's Elevidys - Benzinga
- 17 days ago - Roche presents new insights in Alzheimer's disease research across its diagnostics and pharmaceutical portfolios at AAIC - GlobeNewsWire